Table 2.
Odds ratio and 95% confidence intervals of cholangiocarcinoma associated with statin uses
| Variable | Cases/Controls 3174/3174 | OR | (95% CI) |
|---|---|---|---|
| Medications | n1/n2 | ||
| All statins | 720/840 | 0.80 | (0.71, 0.90)*** |
| Individual statin | |||
| Simvastatin | 262/368 | 0.68 | (0.57, 0.80)*** |
| Lovastatin | 244/337 | 0.69 | (0.58, 0.83)*** |
| Pravastatin | 131/197 | 0.65 | (0.52, 0.82)*** |
| Fluvastatin | 143/183 | 0.77 | (0.61, 0.96)* |
| Atorvastatin | 357/489 | 0.69 | (0.60, 0.80)*** |
| Rosuvastatin | 141/210 | 0.65 | (0.52, 0.82)*** |
n, number of persons on the medicine.
**
P < 0.01,
***
P < 0.001